661 studies found for:    Erythropoietin
Show Display Options
Rank Status Study
1 Completed Comparison Among Erythropoietin Stimulating Agents
Condition: Anemia of End Stage Renal Disease
Interventions: Drug: Epoetin alpha or beta (Epoetin group);   Drug: Darbepoetin alfa;   Drug: Methoxy polyethylene glycol-epoetin beta
2 Active, not recruiting Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Conditions: Anemia;   Chronic Kidney Disease (CKD)
Interventions: Drug: HX575 epoetin alfa;   Drug: US-licensed epoetin alfa
3 Completed
Has Results
Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy
Condition: Cerebral Palsy
Interventions: Biological: Umbilical Cord Blood Infusion;   Drug: Erythropoietin Injection;   Other: Active Rehabilitation;   Other: Placebo Umbilical Cord Blood;   Other: Placebo Erythropoietin
4 Terminated
Has Results
Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa
Condition: Subarachnoid Hemorrhage
Interventions: Drug: Epoetin alfa;   Drug: Saline
5 Withdrawn Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia
Condition: Anemia
Intervention: Drug: Epoetin Alfa plus Iron
6 Active, not recruiting HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)
Condition: Chronic Kidney Disease
Intervention: Drug: HX575 epoetin alfa (Sandoz)
7 Terminated
Has Results
An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy
Condition: Anemia - Cancer Related
Intervention: Drug: Erythropoietin: Observational study
8 Active, not recruiting
Has Results
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
Conditions: Congenital Heart Disease;   Hypoplastic Left Heart Syndrome;   Transposition of the Great Arteries;   Aortic Arch Hypoplasia or Interruption
Interventions: Drug: Erythropoetin;   Drug: Normal saline
9 Completed
Has Results
An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease
Condition: Anemia
Interventions: Drug: Epoetin alfa 3 times weekly /once weekly;   Drug: Epoetin alfa once weekly;   Drug: Epoetin alfa once every two weeks
10 Not yet recruiting Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery
Conditions: Heart; Dysfunction Postoperative, Cardiac Surgery;   Anemia, Iron-Deficiency
Intervention: Drug: Erythropoietin subcutaneously and Iron intravenously
11 Completed Blood Sparing Strategies: Single Shot High Dose Erythropoietin Two Days Before Heart Surgery
Condition: Blood Transfusion
Intervention: Drug: Erythropoietin
12 Completed
Has Results
A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndrome;   Leukemia
Intervention: Drug: Procrit
13 Active, not recruiting Efficacy Study of Epoetin Alfa in Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: Epoetin alfa;   Drug: Placebo
14 Completed
Has Results
Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy
Condition: Leukemia
Intervention: Drug: Procrit (epoetin alfa)
15 Unknown  Intraocular Pharmacokinetics of Erythropoietin After Single Intravitreal Injection in Human
Conditions: Pharmacokinetics;   Erythropoietin
Intervention: Procedure: Vitrectomy
16 Completed A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa
Condition: Pure Red-cell Aplasia
Intervention: Drug: No intervention
17 Terminated
Has Results
The Safety and Effectiveness of PROCRIT (Epoetin Alfa) in Patients Undergoing Elective Major Abdominal and/or Pelvic Surgery
Condition: Hemostasis, Surgical
Interventions: Drug: Epoetin alfa;   Drug: Standard of Care
18 Unknown  Relationship Between Erythropoietin Administration and Stress Responses in Trauma Patients
Condition: Multiple Trauma
Interventions: Drug: erythropoietin;   Drug: placebo
19 Terminated
Has Results
A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy
Conditions: Neoplasms;   Anemia;   Cancer
Interventions: Drug: epoetin alfa;   Drug: darbepoetin alfa
20 Withdrawn A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies
Condition: Anemia
Intervention: Drug: No intervention

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years